Package Insert: Information for the Patient
Paliperidona ratiopharm 3 mg prolonged-release tablets EFG
Paliperidona ratiopharm 6 mg prolonged-release tablets EFG
Paliperidona ratiopharm 9 mg prolonged-release tablets EFG
Read this package insert carefully before starting to take this medicine, as it contains important information for you.
Paliperidone ratiopharm contains the active ingredient paliperidone, which belongs to the class ofmedicamentosantipsicóticos.
Paliperidone is used to treat schizophrenia in adults and adolescents aged 15 years and older.
Schizophrenia is a disorder that causes symptoms that include hearing, seeing or feeling things thatdonotexist, holding false beliefs, having an abnormal distrust, withdrawing into oneself,speaking incoherently and flattening of behavior and emotion. People with this disorder may also feeldepressed,anxious,guiltyotense.
Paliperidone is also used to treat schizoaffective disorder in adults.
Schizoaffective disorder is a mental condition in which the person experiences several of the symptoms ofschizophrenia(enumeratedin the previous paragraph) plus symptoms of mood disorder (feeling of euphoria, sadness, agitation, beingdistracted, insomnia, excessive or reduced speech, excessive or reduced appetite, and recurrent thoughts ofsuicidedo).
Paliperidone may help alleviate the symptoms of your illness and prevent its recurrence.
Do not takepaliperidone
-if you are allergic to paliperidone, risperidone, or any of the other ingredients in thismedicine(listed in section6).
Warnings andprecautions
Consult your doctor or pharmacist before starting to take paliperidone.
If you have any of these conditions, please consult your doctor as it may be necessary to adjust your dose or keep you under observation for a while.
Because very rarely, patients treated with paliperidone have been observed to have a dangerously low number of a type of white blood cells necessary to fight infections in the blood, your doctor may check the number of white blood cells.
Paliperidone may cause you to gain weight. Significant weight gain can negatively affect your health. Your doctor will regularly monitor your weight.
In patients treated with paliperidone, diabetes mellitus or worsening of existing diabetes mellitus has been observed. Your doctor should check for signs of increased blood sugar.In patients with pre-existing diabetes mellitus, blood sugar should be regularly monitored.
During cataract surgery in the eye, the pupil (the black circle in the middle of the eye) may not dilate as needed. Additionally, the iris (the colored part of the eye) may become flaccid during surgery and this may cause eye damage.If you are planning to have eye surgery, make sure to inform your ophthalmologist that you are taking thismedicine.
Children andadolescents
Paliperidone should not be administered to children and adolescents under 15 years old for the treatment ofschizophrenia.
Paliperidone should not be administered to children and adolescents under 18 years old for the treatment ofschizoaffectivedisorder.
This is because the safety and efficacy of paliperidone in this age group are unknown.
Othermedicines and paliperidone
Inform your doctor or pharmacist if you are using, have used recently, or may take other medicines.
Abnormalities in heart function may occur when this medicine is taken with other medicines for heart rhythm control or other medicines such as antihistamines, antimalarials, orantipsicótics.
Since this medicine primarily acts on the brain, this medicine may interfere with other medicines (or alcohol) that also act on it, due to the sum of effects on brain function.
This medicine may lower blood pressure, so you should be careful if you take this medicine with other medicines that also lower blood pressure.
This medicine may reduce the effect of medicines for Parkinson's disease and restless legs syndrome (e.g.,levodopa).
The effects of this medicine may be affected if you take medicines that influence the speed of intestinal movement (e.g.,metoclopramida).
Reduction of this medicine dose should be considered when administered withvalproato.
It is not recommended to use oral risperidone with this medicine as this combination may cause an increase in adverse effects.
Paliperidone should be used with caution with medicines that increase the activity of the central nervous system (psycho-stimulants such as metilphenidato).
Paliperidone and alcohol
You should avoid consuming alcohol during treatment with thismedicine.
Pregnancy andlactation
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before taking thismedicine.
You should not take this medicine during pregnancy unless you have discussed it with your doctor.
The following symptoms may occur in newborn babies of mothers who have been treated with paliperidone in the last three months of pregnancy (last three months of your pregnancy): tremor, rigidity, and/or muscle weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.
You should not breastfeed your baby while taking this medicine.
Driving and use ofmachinery
During treatment with this medicine, dizziness and vision problems may occur (see section 4, Possible side effects). This should be taken into account when requiring maximum attention, for example, when driving or operatingmachinery.
Paliperidone ratiopharm contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet, which may be considered as “sodium-free”.
Follow exactly the administration instructions of this medication indicated by yourmedic,pharmaceutic.
Use inadults
The recommended dose in adults is 6 mg once a day in the morning. Your doctormaybecaninglyadjustthedosagewithintherangeof3mgto12mgoncedayincasesofschizophreniaorof6mgto12mgoncedayincasesofschizoaffective.
Use inadolescents
The initial recommended dose for the treatment of schizophrenia in adolescents aged 15 years or older is 3 mg once a day taken in the morning.
For adolescents weighing 51 kg or more, the dose can be increased within the range of 6 mg to12mgonceday.
For adolescents weighing less than 51 kg, the dose can be increased to 6 mg once a day.
Your doctor will decide how much to administer to you. The amount you take depends on how well the medication works inyourbody.
How and when to take paliperidone
This medication should be taken by mouth, swallowed whole with water or other liquids. It cannot bemasticated,romped,norbroken.
This medication should be taken in the mornings with breakfast or on an empty stomach, but every day in the same way. Do not alternate between taking the medication one day with breakfast and the next day on an empty stomach.
The active ingredient, paliperidone, dissolves once swallowed, and the coating of the tablet is eliminated by thehealthys.
Patients with kidney problems
Your doctor may adjust your dose of this medication according to yourrenalfunction.
Patients of advanced age
Your doctor may reduce your medication dose if your renal function isreduced.
If you take more paliperidone than you should
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or go to the nearest hospital immediately, or call the Toxicological Information Service. Phone: 91 562 04 20 indicating the medication and the amount ingested. You may experience drowsiness,sleepiness,abnormalmovements,problemsforpermanencenttostand,andalterationsoftheheart.
If you forgot to take paliperidone
Do not take a double dose to compensate for the missed doses. If you forget a dose, take the next dose the following day. If you forget two or more doses, contact yourdoctor.
If you interrupt the treatment with paliperidone
Do not stop taking this medication as you will lose the effects of the medication. Do not stop taking this medication unless your doctor tells you to, as the symptoms may reappear.
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Inform your doctor immediately if you experience any of the following:
• Blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness of the leg), which can travel through the blood vessels to the lungs causing chest pain and difficulty breathing. If you experience any of these symptoms, seek medical advice.
• Dementia and a sudden change in your mental state or sudden weakness or numbness in the face, arms, or legs, especially on one side, or difficulty speaking even for a short period of time. These may be signs of a heart attack.
• Fever, muscle stiffness, sweating, or a decrease in consciousness (a condition known as "Neuroleptic Malignant Syndrome"). You may need medical treatment.
• Men: a prolonged or painful erection (priapism). You may need medical treatment.
• Uncontrollable movements of the tongue, mouth, or face. You may need to stop taking this medicine.
• A severe allergic reaction characterized by fever, swelling of the mouth, face, lips, or tongue, difficulty breathing, hives, and sometimes a decrease in blood pressure (anaphylactic reaction).
Very common (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Unknown (frequency cannot be estimated from available data):
The following side effects have appeared with the use of another medication called risperidone, which is very similar to paliperidone, so it is also expected to appear with paliperidone:
Other types of blood vessel problems in the brain, crepitant sounds from the lungs, severe or potentially fatal skin rash with blisters and peeling of the skin that may start in the mouth, nose, eyes, and genitals and spread to other areas of the body (Stevens-Johnson syndrome/toxic epidermal necrolysis). Eye problems may also occur during cataract surgery. During cataract surgery, a condition called intraoperative floppy iris syndrome (IFIS) may occur if you are taking or have taken paliperidone. If you need to undergo cataract surgery, make sure to inform your eye surgeon if you are taking or have taken this medication.
Additional side effects in adolescents:
Adolescents generally experienced side effects similar to those found in adults, except for the following side effects that were detected more frequently:
Reporting of side effects:
If you experience side effects, consult your doctor, pharmacist, or nurse, even if the side effects do not appear in this prospectus. You can also report them directly to the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and blister after CAD or EXP. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
This medication does not require special temperature conditions for its conservation.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Paliperidone ratiopharm
Appearance of the product and contents of the packaging
3 mg: Film-coated, round, biconvex, white to off-white tablets with possible uneven surface and printed with the mark P3 on one side of the tablet. Diameter: approximately 9mm.
6 mg:Film-coated, round, biconvex, yellowish-brown tablets with possible uneven surface and printed with the mark P6 on one side of the tablet. Diameter: approximately 9mm.
9 mg:Film-coated, round, biconvex, pale pink tablets with possible uneven surface and printed with the mark P9 on one side of the tablet. Diameter: approximately 9mm.
Paliperidone ratiopharm is available in boxes containing:
Not all packaging sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
ratiopharm España, S.A.
c/ Anabel Segura, 11, Edificio Albatros B, 1st floor,
Alcobendas, 28108 Madrid (Spain)
Manufacturer:
KRKA, d.d., Novo mesto
Šmarješka cesta 6
8501
Slovenia
Last revision date of thisleaflet:November 2024
The detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.